114 related articles for article (PubMed ID: 8431490)
1. Amphipathic alpha-helical peptides based on surfactant apoprotein SP-A.
McLean LR; Lewis JE; Hagaman KA; Owen TJ; Jackson RL
Biochim Biophys Acta; 1993 Feb; 1166(1):31-8. PubMed ID: 8431490
[TBL] [Abstract][Full Text] [Related]
2. Mixtures of synthetic peptides and dipalmitoylphosphatidylcholine as lung surfactants.
McLean LR; Krstenansky JL; Jackson RL; Hagaman KA; Olsen KA; Lewis JE
Am J Physiol; 1992 Mar; 262(3 Pt 1):L292-300. PubMed ID: 1550252
[TBL] [Abstract][Full Text] [Related]
3. An amphipathic alpha-helical decapeptide in phosphatidylcholine is an effective synthetic lung surfactant.
McLean LR; Lewis JE; Krstenansky JL; Hagaman KA; Cope AS; Olsen KF; Matthews ER; Uhrhammer DC; Owen TJ; Payne MH
Am Rev Respir Dis; 1993 Feb; 147(2):462-5. PubMed ID: 8430972
[TBL] [Abstract][Full Text] [Related]
4. Role of the hydrophobic face of amphipathic alpha-helical peptides in synthetic pulmonary surfactants.
McLean LR; Lewis JE; Hagaman KA; Owen TJ; Matthews ER
J Pharmacol Exp Ther; 1993 Aug; 266(2):551-6. PubMed ID: 8355190
[TBL] [Abstract][Full Text] [Related]
5. The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants.
Revak SD; Merritt TA; Hallman M; Heldt G; La Polla RJ; Hoey K; Houghten RA; Cochrane CG
Pediatr Res; 1991 May; 29(5):460-5. PubMed ID: 1896249
[TBL] [Abstract][Full Text] [Related]
6. Synthetic peptide-containing surfactants--evaluation of transmembrane versus amphipathic helices and surfactant protein C poly-valyl to poly-leucyl substitution.
Nilsson G; Gustafsson M; Vandenbussche G; Veldhuizen E; Griffiths WJ; Sjövall J; Haagsman HP; Ruysschaert JM; Robertson B; Curstedt T; Johansson J
Eur J Biochem; 1998 Jul; 255(1):116-24. PubMed ID: 9692909
[TBL] [Abstract][Full Text] [Related]
7. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants.
Hall SB; Venkitaraman AR; Whitsett JA; Holm BA; Notter RH
Am Rev Respir Dis; 1992 Jan; 145(1):24-30. PubMed ID: 1731593
[TBL] [Abstract][Full Text] [Related]
8. Cellular uptake and processing of surfactant lipids and apoprotein SP-A by rat lung.
Young SL; Wright JR; Clements JA
J Appl Physiol (1985); 1989 Mar; 66(3):1336-42. PubMed ID: 2708254
[TBL] [Abstract][Full Text] [Related]
9. Surfactant protein B: lipid interactions of synthetic peptides representing the amino-terminal amphipathic domain.
Bruni R; Taeusch HW; Waring AJ
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7451-5. PubMed ID: 1871144
[TBL] [Abstract][Full Text] [Related]
10. Biophysical inhibition of synthetic phospholipid-lung surfactant apoprotein admixtures by plasma proteins.
Venkitaraman AR; Baatz JE; Whitsett JA; Hall SB; Notter RH
Chem Phys Lipids; 1991; 57(1):49-57. PubMed ID: 2060063
[TBL] [Abstract][Full Text] [Related]
11. Characterization of poly-leucine substituted analogues of the human surfactant protein SP-C.
Takei T; Hashimoto Y; Ohtsubo E; Sakai K; Ohkawa H
Biol Pharm Bull; 1996 Dec; 19(12):1550-5. PubMed ID: 8996637
[TBL] [Abstract][Full Text] [Related]
12. A synthetic segment of surfactant protein A: structure, in vitro surface activity, and in vivo efficacy.
Walther FJ; David-Cu R; Leung C; Bruni R; Hernández-Juviel J; Gordon LM; Waring AJ
Pediatr Res; 1996 Jun; 39(6):938-46. PubMed ID: 8725252
[TBL] [Abstract][Full Text] [Related]
13. Analysis of binding and membrane destabilization of phospholipid membranes by surfactant apoprotein B.
Chang R; Nir S; Poulain FR
Biochim Biophys Acta; 1998 May; 1371(2):254-64. PubMed ID: 9630660
[TBL] [Abstract][Full Text] [Related]
14. [Recent advances in molecular biology with respect to pulmonary surfactant apoproteins].
Kuroki Y; Ogasawara Y
Nihon Rinsho; 1996 Feb; 54(2):334-40. PubMed ID: 8838078
[TBL] [Abstract][Full Text] [Related]
15. Biophysical and biological activity of a synthetic 8.7-kDa hydrophobic pulmonary surfactant protein SP-B.
Sarin VK; Gupta S; Leung TK; Taylor VE; Ohning BL; Whitsett JA; Fox JL
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2633-7. PubMed ID: 2320580
[TBL] [Abstract][Full Text] [Related]
16. Role of bovine pulmonary surfactant-associated proteins in the surface-active property of phospholipid mixtures.
Yu SH; Possmayer F
Biochim Biophys Acta; 1990 Oct; 1046(3):233-41. PubMed ID: 2223863
[TBL] [Abstract][Full Text] [Related]
17. Lipid bilayer surface association of lung surfactant protein SP-B, amphipathic segment detected by flow immunofluorescence.
Longo ML; Waring A; Zasadzinski JA
Biophys J; 1992 Sep; 63(3):760-73. PubMed ID: 1420912
[TBL] [Abstract][Full Text] [Related]
18. Hydrophobic homopolymeric peptides enhance the biophysical activity of synthetic lung phospholipids.
Venkitaraman AR; Hall SB; Notter RH
Chem Phys Lipids; 1990 Mar; 53(2-3):157-64. PubMed ID: 2337975
[TBL] [Abstract][Full Text] [Related]
19. The role of charged amphipathic helices in the structure and function of surfactant protein B.
Waring AJ; Walther FJ; Gordon LM; Hernandez-Juviel JM; Hong T; Sherman MA; Alonso C; Alig T; Braun A; Bacon D; Zasadzinski JA
J Pept Res; 2005 Dec; 66(6):364-74. PubMed ID: 16316452
[TBL] [Abstract][Full Text] [Related]
20. Surfactant with SP-B and SP-C analogues improves lung function in surfactant-deficient rats.
Walther FJ; Hernández-Juviel JM; Mercado PE; Gordon LM; Waring AJ
Biol Neonate; 2002; 82(3):181-7. PubMed ID: 12373069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
